Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Teva UK launches website for patients with chronic conditions

Teva UK has launched a website to support patients with chronic conditions as part of a visual identity change that includes a new logo.

Teva launched the website Life Effects last week (September 4) to give first-hand perspectives on living with a chronic condition, such as multiple sclerosis or migraine, through articles, videos and podcasts.

“Shaped by patients for patients,” Teva developed Life Effects after speaking to more than 1,000 patients on how best to support them, it said.

The manufacturer will also roll out a new logo (pictured) on its medicines packaging from 2020.

Teva UK and Ireland general manager Kim Innes said: “New initiatives such as the Life Effects platform, new next-generation packs and our support for pharmacies strengthen our position as a leading contributor to patient health and wellbeing across the UK.”

For more information, visit the Life Effects website

How do you support patients with chronic conditions?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006084

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel